Publications by authors named "Rocio Leton"

Claim this Profile
M
Molecular profiling unveils genetic complexity and identifies potential new driver mechanisms in head and neck paragangliomas.
Sara Mellid, Eduardo Caleiras, Ángel M Martínez-Montes, Alicia Arenas, Scherezade Jiménez

Genes Dis· March 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Homo Sapiens (Hsa)-miR-139-5p as a Clinically Feasible Prognostic Marker for Differentiated Thyroid Cancer.
Natalia Martínez-Puente, Ignacio Ruz-Caracuel, Luis J Leandro-García, Héctor Pian-Arias, Zaira Vega-Corral

Lab Invest· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma.
María Monteagudo, Bruna Calsina, Milton E Salazar-Hidalgo, Ángel M Martínez-Montes, Elena Piñeiro-Yáñez

Best Pract Res Clin Endocrinol Metab· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial.
Javier Martin-Broto, Claudia Valverde, Nadia Hindi, Bruno Vincenzi, Javier Martinez-Trufero

Mol Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling.
Sara Mellid, Fernando García, Luis Javier Leandro-García, Alberto Díaz-Talavera, Ángel Mario Martínez-Montes

Cancer Commun (Lond)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-occurrence of mutations in and other susceptibility genes in pheochromocytoma and paraganglioma.
Sara Mellid, Eduardo Gil, Rocío Letón, Eduardo Caleiras, Emiliano Honrado

Front Endocrinol (Lausanne)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma.
Bruna Calsina, Elena Piñeiro-Yáñez, Ángel M Martínez-Montes, Eduardo Caleiras, Ángel Fernández-Sanromán

Nat Commun· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive molecular analysis of immortalization hallmarks in thyroid cancer reveals new prognostic markers.
Cristina Montero-Conde, Luis Javier Leandro-García, Ángel M Martínez-Montes, Paula Martínez, Francisco J Moya

Clin Transl Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients.
Laura Pena-Couso, María Ercibengoa, Fátima Mercadillo, David Gómez-Sánchez, Lucía Inglada-Pérez

Orphanet J Rare Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Telomere Maintenance Related Genes Reveals as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma.
María Monteagudo, Paula Martínez, Luis J Leandro-García, Ángel M Martínez-Montes, Bruna Calsina

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome.
Juan María Roldan-Romero, María Santos, Javier Lanillos, Eduardo Caleiras, Georgia Anguera

Mod Pathol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD133 Expression in Medullary Thyroid Cancer Cells Identifies Patients with Poor Prognosis.
Alfonso Cordero-Barreal, Eduardo Caleiras, Evangelina López de Maturana, María Monteagudo, Ángel M Martínez-Montes

J Clin Endocrinol Metab· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma.
Bruna Calsina, Luis Jaime Castro-Vega, Rafael Torres-Pérez, Lucía Inglada-Pérez, Maria Currás-Freixes

Theranostics· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing.
Cristina Montero-Conde, Osvaldo Graña-Castro, Guillermo Martín-Serrano, Ángel M Martínez-Montes, Eduardo Zarzuela

Int J Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy.
Lara Sánchez-Barroso, Maria Apellaniz-Ruiz, Gerardo Gutiérrez-Gutiérrez, María Santos, Juan M Roldán-Romero

Oncologist· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and mutation.
Susana García-Silva, Alberto Benito-Martín, Sara Sánchez-Redondo, Alberto Hernández-Barranco, Pilar Ximénez-Embún

J Exp Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and mutation.
Susana García-Silva, Alberto Benito-Martín, Sara Sánchez-Redondo, Alberto Hernández-Barranco, Pilar Ximénez-Embún

J Exp Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas.
Laura Remacha, David Pirman, Christopher E Mahoney, Javier Coloma, Bruna Calsina

Am J Hum Genet· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas.
Laura Remacha, David Pirman, Christopher E Mahoney, Javier Coloma, Bruna Calsina

Am J Hum Genet· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma.
Susan Richter, Laura Gieldon, Ying Pang, Mirko Peitzsch, Thanh Huynh, Rocio Leton

Genet Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gain-of-function mutations in DNMT3A in patients with paraganglioma.
Laura Remacha, Maria Currás-Freixes, Raúl Torres-Ruiz, Francesca Schiavi, Rafael Torres-Pérez

Genet Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients.
Bruna Calsina, Maria Currás-Freixes, Alexandre Buffet, Tirso Pons, Laura Contreras

Genet Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Exome Sequencing of Krebs Cycle Genes Reveals Candidate Cancer-Predisposing Mutations in Pheochromocytomas and Paragangliomas.
Laura Remacha, Iñaki Comino-Méndez, Susan Richter, Laura Contreras, María Currás-Freixes

Clin Cancer Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics.
Maria Currás-Freixes, Elena Piñeiro-Yañez, Cristina Montero-Conde, María Apellániz-Ruiz, Bruna Calsina

J Mol Diagn· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATRX driver mutation in a composite malignant pheochromocytoma.
Iñaki Comino-Méndez, Águeda M Tejera, María Currás-Freixes, Laura Remacha, Pablo Gonzalvo

Cancer Genet· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis